Christopher P. Appleton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Christopher P. Appleton has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Amith R. Seri
Department of Cardiovascular Diseases, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA
2 shared publications - Chieh-Ju Chao
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA
2 shared publications Kwan S. Lee
Division of Cardiovascular Diseases, Mayo Clinic Arizona, Scottsdale, AZ
2 shared publicationsR. Todd Hurst
Division of Cardiovascular Diseases, Mayo Clinic Arizona, Scottsdale, AZ
2 shared publications- Reza Arsanjani
Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona, USA
2 shared publications - Steven J. Lester
Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85054, USA
2 shared publications
Latest Publications
- Open Access
- 26 April 2023
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 10 (5) , 192
Transcatheter Aortic Valve Replacement Prognostication with Augmented Mean Arterial Pressure
Background: Post-transcatheter aortic valve replacement (TAVR) patient outcome is an important research topic. To accurately assess post-TAVR mortality, we examined a family of new echo parameters (augmented systolic blood pressure (AugSBP) and arterial mean pressure (AugMAP)) derived from blood pressure and aortic valve gradients. Methods: Patients in the Mayo Clinic National Cardiovascular Diseases Registry-TAVR database who underwent TAVR between 1 January 2012 and 30 June 2017 were identified to retrieve baseline clinical, echocardiographic and mortality data. AugSBP, AugMAP and valvulo-arterial impedance (Zva) (Zva) were evaluated using Cox regression. Receiver operating characteristic curve analysis and the c-index were used to assess the model performance against the Society of Thoracic Surgeons (STS) risk score. Results: The final cohort contained 974 patients with a mean age of 81.4 ± 8.3 years old, and 56.6% were male. The mean STS risk score was 8.2 ± 5.2. The median follow-up duration was 354 days, and the one-year all-cause mortality rate was 14.2%. Both univariate and multivariate Cox regression showed that AugSBP and AugMAP parameters were independent predictors for intermediate-term post-TAVR mortality (all p < 0.0001). AugMAP1 < 102.5 mmHg was associated with a 3-fold-increased risk of all-cause mortality 1-year post-TAVR (hazard ratio 3.0, 95%confidence interval 2.0–4.5, p < 0.0001). A univariate model of AugMAP1 surpassed the STS score model in predicting intermediate-term post-TAVR mortality (area under the curve: 0.700 vs. 0.587, p = 0.005; c-index: 0.681 vs. 0.585, p = 0.001). Conclusions: Augmented mean arterial pressure provides clinicians with a simple but effective approach to quickly identify patients at risk and potentially improve post-TAVR prognosis.
- 26 April 2023
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 10 (5) , 192
Open AccessTranscatheter Aortic Valve Replacement Prognostication with Augmented Mean Arterial Pressure
Background: Post-transcatheter aortic valve replacement (TAVR) patient outcome is an important research topic. To accurately assess post-TAVR mortality, we examined a family of new echo parameters (augmented systolic blood pressure (AugSBP) and arterial mean pressure (AugMAP)) derived from blood pressure and aortic valve gradients. Methods: Patients in the Mayo Clinic National Cardiovascular Diseases Registry-TAVR database who underwent TAVR between 1 January 2012 and 30 June 2017 were identified to retrieve baseline clinical, echocardiographic and mortality data. AugSBP, AugMAP and valvulo-arterial impedance (Zva) (Zva) were evaluated using Cox regression. Receiver operating characteristic curve analysis and the c-index were used to assess the model performance against the Society of Thoracic Surgeons (STS) risk score. Results: The final cohort contained 974 patients with a mean age of 81.4 ± 8.3 years old, and 56.6% were male. The mean STS risk score was 8.2 ± 5.2. The median follow-up duration was 354 days, and the one-year all-cause mortality rate was 14.2%. Both univariate and multivariate Cox regression showed that AugSBP and AugMAP parameters were independent predictors for intermediate-term post-TAVR mortality (all p < 0.0001). AugMAP1 < 102.5 mmHg was associated with a 3-fold-increased risk of all-cause mortality 1-year post-TAVR (hazard ratio 3.0, 95%confidence interval 2.0–4.5, p < 0.0001). A univariate model of AugMAP1 surpassed the STS score model in predicting intermediate-term post-TAVR mortality (area under the curve: 0.700 vs. 0.587, p = 0.005; c-index: 0.681 vs. 0.585, p = 0.001). Conclusions: Augmented mean arterial pressure provides clinicians with a simple but effective approach to quickly identify patients at risk and potentially improve post-TAVR prognosis.
- Open Access
- 18 February 2023
- Published by MDPI AG in Journal of Imaging
- Vol. 9 (2) , 48
Developing an Echocardiography-Based, Automatic Deep Learning Framework for the Differentiation of Increased Left Ventricular Wall Thickness Etiologies
Aims:Increased left ventricular (LV) wall thickness is frequently encountered in transthoracic echocardiography (TTE). While accurate and early diagnosis is clinically important, given the differences in available therapeutic options and prognosis, an extensive workup is often required to establish the diagnosis. We propose the first echo-based, automated deep learning model with a fusion architecture to facilitate the evaluation and diagnosis of increased left ventricular (LV) wall thickness. Methods and Results: Patients with an established diagnosis of increased LV wall thickness (hypertrophic cardiomyopathy (HCM), cardiac amyloidosis (CA), and hypertensive heart disease (HTN)/others) between 1/2015 and 11/2019 at Mayo Clinic Arizona were identified. The cohort was divided into 80%/10%/10% for training, validation, and testing sets, respectively. Six baseline TTE views were used to optimize a pre-trained InceptionResnetV2 model. Each model output was used to train a meta-learner under a fusion architecture. Model performance was assessed by multiclass area under the receiver operating characteristic curve (AUROC). A total of 586 patients were used for the final analysis (194 HCM, 201 CA, and 191 HTN/others). The mean age was 55.0 years, and 57.8% were male. Among the individual view-dependent models, the apical 4-chamber model had the best performance (AUROC: HCM: 0.94, CA: 0.73, and HTN/other: 0.87). The final fusion model outperformed all the view-dependent models (AUROC: HCM: 0.93, CA: 0.90, and HTN/other: 0.92). Conclusion: The echo-based InceptionResnetV2 fusion model can accurately classify the main etiologies of increased LV wall thickness and can facilitate the process of diagnosis and workup.
- 18 February 2023
- Published by MDPI AG in Journal of Imaging
- Vol. 9 (2) , 48
Open AccessDeveloping an Echocardiography-Based, Automatic Deep Learning Framework for the Differentiation of Increased Left Ventricular Wall Thickness Etiologies
Aims:Increased left ventricular (LV) wall thickness is frequently encountered in transthoracic echocardiography (TTE). While accurate and early diagnosis is clinically important, given the differences in available therapeutic options and prognosis, an extensive workup is often required to establish the diagnosis. We propose the first echo-based, automated deep learning model with a fusion architecture to facilitate the evaluation and diagnosis of increased left ventricular (LV) wall thickness. Methods and Results: Patients with an established diagnosis of increased LV wall thickness (hypertrophic cardiomyopathy (HCM), cardiac amyloidosis (CA), and hypertensive heart disease (HTN)/others) between 1/2015 and 11/2019 at Mayo Clinic Arizona were identified. The cohort was divided into 80%/10%/10% for training, validation, and testing sets, respectively. Six baseline TTE views were used to optimize a pre-trained InceptionResnetV2 model. Each model output was used to train a meta-learner under a fusion architecture. Model performance was assessed by multiclass area under the receiver operating characteristic curve (AUROC). A total of 586 patients were used for the final analysis (194 HCM, 201 CA, and 191 HTN/others). The mean age was 55.0 years, and 57.8% were male. Among the individual view-dependent models, the apical 4-chamber model had the best performance (AUROC: HCM: 0.94, CA: 0.73, and HTN/other: 0.87). The final fusion model outperformed all the view-dependent models (AUROC: HCM: 0.93, CA: 0.90, and HTN/other: 0.92). Conclusion: The echo-based InceptionResnetV2 fusion model can accurately classify the main etiologies of increased LV wall thickness and can facilitate the process of diagnosis and workup.
- 1 January 2009
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 2 (1) , 6-9
The Role of Left Atrial Function in Diastolic Heart Failure
Ew heart failure affects 500 000 Americans yearly. Nearly 50% of these patients have a normal left ven- tricular ejection fraction (LVEF) or so-called diastolic heart failure (DHF). New onset symptomatic DHF is a lethal disease with a 5-year mortality that approaches 50%.1 Echo- Doppler techniques use LV filling patterns and tissue Doppler imaging of the mitral annulus to help identify and classify the degree of LV diastolic dysfunction, but work best in symp- tomatic patients with advanced disease.2 Therefore, the diag- nosis of early diastolic dysfunction, when asymptomatic and most treatable, remains problematic. A detailed causality-based, mechanistic understanding of what causes DHF, and how to most easily detect it, remains one of the most important unsolved problems in cardiovascular physiology and clinical cardiology.3 Article see p 10 Segmental LV deformation analysis for calculating con- tractile parameters such as strain and strain rate is now possible using noninvasive echo-Doppler techniques.2 It has been reported that LA systolic and diastolic function can also be assessed using these Doppler strain techniques.4-6 Al- though LA enlargement increases with the severity of dia- stolic dysfunction,7 the ability of LA volume measurements to discriminate asymptomatic LV diastolic dysfunction from early DHF heart failure has not been possible. However, the concept that an alteration in LA function or stiffness may indicate this change is appealing.
- 1 January 2009
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 2 (1) , 6-9
The Role of Left Atrial Function in Diastolic Heart Failure
Ew heart failure affects 500 000 Americans yearly. Nearly 50% of these patients have a normal left ven- tricular ejection fraction (LVEF) or so-called diastolic heart failure (DHF). New onset symptomatic DHF is a lethal disease with a 5-year mortality that approaches 50%.1 Echo- Doppler techniques use LV filling patterns and tissue Doppler imaging of the mitral annulus to help identify and classify the degree of LV diastolic dysfunction, but work best in symp- tomatic patients with advanced disease.2 Therefore, the diag- nosis of early diastolic dysfunction, when asymptomatic and most treatable, remains problematic. A detailed causality-based, mechanistic understanding of what causes DHF, and how to most easily detect it, remains one of the most important unsolved problems in cardiovascular physiology and clinical cardiology.3 Article see p 10 Segmental LV deformation analysis for calculating con- tractile parameters such as strain and strain rate is now possible using noninvasive echo-Doppler techniques.2 It has been reported that LA systolic and diastolic function can also be assessed using these Doppler strain techniques.4-6 Al- though LA enlargement increases with the severity of dia- stolic dysfunction,7 the ability of LA volume measurements to discriminate asymptomatic LV diastolic dysfunction from early DHF heart failure has not been possible. However, the concept that an alteration in LA function or stiffness may indicate this change is appealing.
- Open Access
- 24 November 2008
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 14 (12) , 1691-1693
Reducing Coronary Artery Disease Events in Liver Transplant Patients: Moving Toward Identifying the Vulnerable Patient
- 24 November 2008
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 14 (12) , 1691-1693
Open AccessReducing Coronary Artery Disease Events in Liver Transplant Patients: Moving Toward Identifying the Vulnerable Patient
- Open Access
- 28 May 2008
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 14 (6) , 886-892
Preoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events after orthotopic liver transplantation
Cardiovascular (CV) complications are the leading cause of non–graft-related death in orthotopic liver transplant (OLT) patients. Pretransplant cardiac evaluation using dobutamine stress echocardiography (DSE) is commonly utilized for risk stratification of OLT candidates. To determine if clinical and echocardiographic variables identify patients with increased CV risk, we performed a retrospective chart review of all 284 patients that underwent OLT at our institution between June 1999 and August 2005. Of these patients, 157 had a DSE prior to their OLT. Serious adverse CV events occurring during surgery and up to 4 months post-transplantation were defined as cardiac-related death, myocardial infarction (MI), new heart failure, or asystole or unstable ventricular arrhythmia requiring acute treatment. Sixteen of 157 patients (10%) had an adverse CV event with 2 deaths. These included ventricular tachycardia (n = 8), asystole (n = 2), MI (n = 5), and new heart failure (n = 1). Nine of the 16 CV events occurred at the time of surgery (including both deaths), 5 occurred postoperatively, and 3 occurred after hospital discharge. Variables that correlated with increased CV events were inability during DSE to achieve >82% of the maximum predicted heart rate (22% versus 6%, P = 0.01), a peak rate pressure product during DSE of 24 at the time of OLT. A multivariate model calculated from the DSE maximum achieved heart rate (MAHR) and MELD score (result = 3.78 + 0.07 MELD − 0.05 MAHR) identified a 47% risk for a value > 0 versus a 6% risk for a value < 0 (P < 0.001). In conclusion, the maximum heart rate achieved during DSE together with the MELD score may be a predictor of adverse CV events up to 4 months post-OLT. A large prospective study is needed to more decisively support this conclusion. Liver Transpl 14:886–892, 2008. © 2008 AASLD.
- 28 May 2008
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 14 (6) , 886-892
Open AccessPreoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events after orthotopic liver transplantation
Cardiovascular (CV) complications are the leading cause of non–graft-related death in orthotopic liver transplant (OLT) patients. Pretransplant cardiac evaluation using dobutamine stress echocardiography (DSE) is commonly utilized for risk stratification of OLT candidates. To determine if clinical and echocardiographic variables identify patients with increased CV risk, we performed a retrospective chart review of all 284 patients that underwent OLT at our institution between June 1999 and August 2005. Of these patients, 157 had a DSE prior to their OLT. Serious adverse CV events occurring during surgery and up to 4 months post-transplantation were defined as cardiac-related death, myocardial infarction (MI), new heart failure, or asystole or unstable ventricular arrhythmia requiring acute treatment. Sixteen of 157 patients (10%) had an adverse CV event with 2 deaths. These included ventricular tachycardia (n = 8), asystole (n = 2), MI (n = 5), and new heart failure (n = 1). Nine of the 16 CV events occurred at the time of surgery (including both deaths), 5 occurred postoperatively, and 3 occurred after hospital discharge. Variables that correlated with increased CV events were inability during DSE to achieve >82% of the maximum predicted heart rate (22% versus 6%, P = 0.01), a peak rate pressure product during DSE of 24 at the time of OLT. A multivariate model calculated from the DSE maximum achieved heart rate (MAHR) and MELD score (result = 3.78 + 0.07 MELD − 0.05 MAHR) identified a 47% risk for a value > 0 versus a 6% risk for a value < 0 (P < 0.001). In conclusion, the maximum heart rate achieved during DSE together with the MELD score may be a predictor of adverse CV events up to 4 months post-OLT. A large prospective study is needed to more decisively support this conclusion. Liver Transpl 14:886–892, 2008. © 2008 AASLD.
- 1 January 2007
- Published by Elsevier in The American Journal of Cardiology
- Vol. 99 (1) , 113-118
Relation of Electrocardiographic Criteria for Left Atrial Enlargement to Two-Dimensional Echocardiographic Left Atrial Volume Measurements
- 1 January 2007
- Published by Elsevier in The American Journal of Cardiology
- Vol. 99 (1) , 113-118
Relation of Electrocardiographic Criteria for Left Atrial Enlargement to Two-Dimensional Echocardiographic Left Atrial Volume Measurements
- 1 August 2000
- Published by Elsevier in Cardiology Clinics
- Vol. 18 (3) , 513-546
THE ECHO-DOPPLER EVALUATION OF LEFT VENTRICULAR DIASTOLIC FUNCTION
- 1 August 2000
- Published by Elsevier in Cardiology Clinics
- Vol. 18 (3) , 513-546
THE ECHO-DOPPLER EVALUATION OF LEFT VENTRICULAR DIASTOLIC FUNCTION